First Time Loading...
A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 2.9 NZD -2.36% Market Closed
Updated: May 7, 2024

AFT Pharmaceuticals Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AFT Pharmaceuticals Ltd
Cash from Financing Activities Peer Comparison

Comparables:
BLT
CBD
RUA
G
GFI

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
A
AFT Pharmaceuticals Ltd
NZX:AFT
Cash from Financing Activities
-NZ$7.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BLIS Technologies Ltd
NZX:BLT
Cash from Financing Activities
-NZ$275k
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cannasouth Ltd
NZX:CBD
Cash from Financing Activities
NZ$2.1m
CAGR 3-Years
-30%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Rua Bioscience Ltd
NZX:RUA
Cash from Financing Activities
-NZ$120.4k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Greenfern Industries Ltd
NZX:GFI
Cash from Financing Activities
NZ$2.1m
CAGR 3-Years
112%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is AFT Pharmaceuticals Ltd's Cash from Financing Activities?
Cash from Financing Activities
-7.2m NZD

Based on the financial report for Sep 30, 2023, AFT Pharmaceuticals Ltd's Cash from Financing Activities amounts to -7.2m NZD.

What is AFT Pharmaceuticals Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-80%

Over the last year, the Cash from Financing Activities growth was -80%.